Chiang, Nicholas http://orcid.org/0000-0002-9488-9917
Sibbald, Cathryn http://orcid.org/0000-0001-9288-1121
Levy, Rebecca http://orcid.org/0000-0002-5407-3972
Lara-Corrales, Irene http://orcid.org/0000-0002-3210-3413
Article History
Accepted: 11 September 2023
First Online: 2 October 2023
Declarations
:
: Not applicable.
: N.C. previously worked for Eli Lilly as Medical Information Associate for dermatology and rheumatology and has no other conflicts to declare. C.S. has received honoraria from AbbVie, LEO, Pfizer, Miravo, Novartis, UCB, Sanofi/Regeneron, none of which are directly related to this manuscript. R.L. has received honoraria from Sanofi, AbbVie and L’Oreal and has been a consultant for Sanofi, L’Oreal, Alexion and Celltrion, none of which are directly related to this manuscript. I.L.C. has been an Investigator/or received research support from AbbVie, Eli Lilly, Arcutis, SkIN Canada, La Roche Posse, Sanofi Genzyme, Regeneron; has been a Consultant/Advisor for Sanofi Genzyme, Abeona, Avicanna, Novartis, Eli Lilly; has participated in Speaker bureau for Sanofi Genzyme, AbbVie, Eli Lilly; none of these are directly related to this manuscript.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: NC conducted the search and synthesized the results. NC, CS, RL, and ILC wrote and edited the manuscript. All authors read and approved the final manuscript.